Conservative treatment of chronic obliterating diseases of lower limb arteries
https://doi.org/10.21518/1995-14772018-1-2-14-19
Abstract
About the Authors
V. YU. BogachevRussian Federation
B. V. Boldin
Russian Federation
S. V. Rodionov
Russian Federation
P. YU. Turkin
Russian Federation
References
1. ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg, 2018: 1-64. In press.
2. Dormandy J, Nehler M, Harris K, Fowkes F on behalf of the TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1).
3. Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J, 1982, 104: 66-72.
4. Di Perri T, Guerrini M. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Angiology, 1983, 34: 40-45.
5. Таричко Ю.В., Зудин А.М., Учкин И.Г., Талов Н.А., Хмырова А.В. Опыт применения пентоксифиллина пролонгированного действия в комплексном лечении трофических дефектов тканей при критической ишемии нижних конечностей. Фарматека, 2011, 10: 66-69./ Tarichko YuV, Zudin AM, Uchkin IG, Talov NA, Khmyrova AV. Experience in using sustained action pentoxifylline in the combination treatment of trophic tissue defects in criticallowerlimb ischemia. Farmateka, 2011, 10: 66-69.
Review
For citations:
Bogachev V.Yu., Boldin B.V., Rodionov S.V., Turkin P.Yu. Conservative treatment of chronic obliterating diseases of lower limb arteries. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2018;(1-2):14-19. (In Russ.) https://doi.org/10.21518/1995-14772018-1-2-14-19

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.